Page last updated: 2024-08-21

d-alpha tocopherol and Atrial Fibrillation

d-alpha tocopherol has been researched along with Atrial Fibrillation in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's11 (84.62)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aigner, I; Schimetta, W; Stanger, O; Wonisch, W1
Basili, S; Cangemi, R; Carnevale, R; Corazza, GR; Davì, G; Farcomeni, A; Ferro, D; Hiatt, WR; Licata, G; Lip, GY; Loffredo, L; Mannucci, PM; Pastori, D; Pignatelli, P; Vestri, A; Violi, F1
Aguayo, R; Asenjo, R; Baeza, C; Carrasco, R; Castillo, R; Cereceda, M; Gormaz, JG; Korantzopoulos, P; Rodrigo, R; Villalabeitia, E; Zamorano, J1
Bartimoccia, S; Cangemi, R; Carnevale, R; Farcomeni, A; Nocella, C; Pastori, D; Pignatelli, P; Saliola, M; Vicario, T; Violi, F1
Chen, YW; Dong, JZ; Du, X; Guo, XY; Ma, CS; Tang, RB; Yan, XL1
Angelini, GD; Ascione, R; James, AF; Suleiman, MS; Zakkar, M1
Albert, CM; Buring, JE; Conen, D; Glynn, RJ; Koplan, BA; Tedrow, UB1
Araya, J; Asenjo, R; Castillo, R; Castillo-Koch, R; Cereceda, M; Espinoza, J; Larraín, E; Rodrigo, R; Vinay, J; Zamorano, J1
Barrios, V; Echarri, R; Escobar, C1
Albert, CM; Buring, JE; Chae, CU; Conen, D; Everett, BM; Glynn, RJ; Tedrow, UB1
Cangemi, R; Carnevale, R; Catasca, E; Ferro, D; Franciosa, P; Loffredo, L; Perri, L; Pignatelli, P; Violi, F1
Fernández, R; Gutiérrez, R; Guzmán, P; Rodrigo, R1
Lavoie, J; Nattel, S; Schram, G; Shiroshita-Takeshita, A1

Reviews

3 review(s) available for d-alpha tocopherol and Atrial Fibrillation

ArticleYear
Omega-3 fatty acids for postoperative atrial fibrillation: alone or in combination with antioxidant vitamins?
    Heart, lung & circulation, 2014, Volume: 23, Issue:8

    Topics: Antioxidants; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Fatty Acids, Omega-3; Female; Humans; Male; Postoperative Complications; PubMed; Randomized Controlled Trials as Topic; Vitamin E; Vitamins

2014
Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery.
    Pharmacology & therapeutics, 2015, Volume: 154

    Topics: Adrenal Cortex Hormones; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Colchicine; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Myocardial Reperfusion Injury; Oxidative Stress; Postoperative Complications; Reactive Oxygen Species; Risk Factors; Systemic Inflammatory Response Syndrome; Vitamin E

2015
Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation.
    International journal of cardiology, 2010, Feb-04, Volume: 138, Issue:3

    Topics: Antioxidants; Ascorbic Acid; Atrial Fibrillation; Humans; Myocardial Reperfusion Injury; Oxidative Stress; Postoperative Complications; Vitamin E

2010

Trials

3 trial(s) available for d-alpha tocopherol and Atrial Fibrillation

ArticleYear
Antioxidant supplementation attenuates oxidative stress in patients undergoing coronary artery bypass graft surgery.
    The Tohoku journal of experimental medicine, 2014, Volume: 232, Issue:2

    Topics: alpha-Tocopherol; Antibodies; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Fatty Acids, Omega-3; Fluorescence; Humans; Lipoproteins, LDL; Oxidation-Reduction; Oxidative Stress; Peroxidase; Peroxides

2014
A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.
    Journal of the American College of Cardiology, 2013, Oct-15, Volume: 62, Issue:16

    Topics: Antioxidants; Ascorbic Acid; Atrial Fibrillation; Biomarkers; Cardiac Surgical Procedures; Dietary Supplements; Drug Monitoring; Fatty Acids, Omega-3; Female; Humans; Inflammation; Male; Middle Aged; Outcome Assessment, Health Care; Oxidative Stress; Postoperative Complications; Treatment Outcome; Vitamin E

2013
Ageing improves the antioxidant response against postoperative atrial fibrillation: a randomized controlled trial.
    Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Biomarkers; Cardiac Surgical Procedures; Catalase; Chile; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Extracorporeal Circulation; Fatty Acids, Omega-3; Glutathione Peroxidase; Heart Atria; Humans; Kaplan-Meier Estimate; Malondialdehyde; Middle Aged; Oxidative Stress; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Superoxide Dismutase; Time Factors; Treatment Outcome; Vitamin E

2012

Other Studies

7 other study(ies) available for d-alpha tocopherol and Atrial Fibrillation

ArticleYear
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.
    International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Cholesterol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Vitamin E

2013
Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort study.
    Journal of the American Heart Association, 2013, Oct-28, Volume: 2, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Clinical Trials as Topic; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vitamin E; Warfarin

2013
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.
    Circulation, 2009, Apr-28, Volume: 119, Issue:16

    Topics: Adult; Antioxidants; Aspirin; Atrial Fibrillation; Blood Pressure; Cohort Studies; Diastole; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Systole; Vitamin E

2009
Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women".
    Circulation, 2010, Feb-09, Volume: 121, Issue:5

    Topics: Adult; Antioxidants; Aspirin; Atrial Fibrillation; Blood Pressure; Cohort Studies; Diastole; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Systole; Vitamin E

2010
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.
    JAMA, 2011, May-25, Volume: 305, Issue:20

    Topics: Aspirin; Atrial Fibrillation; Cause of Death; Female; Follow-Up Studies; Health Personnel; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Stroke; United States; Vitamin E; Vitamins

2011
Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion.
    Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:2

    Topics: Aged; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Dinoprost; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Recurrence; Retrospective Studies; Vitamin E

2012
Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.
    Circulation, 2004, Oct-19, Volume: 110, Issue:16

    Topics: Animals; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Calcium Channels, L-Type; Cardiac Pacing, Artificial; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Oxidative Stress; Refractory Period, Electrophysiological; Simvastatin; Vitamin E

2004